Replies to post #178016 on Biotech Values

[genisi]

KMDA final results of phase-2/3 inhaled AAT trial

It appears the trial missed the primary and secondary endpoints for the ITT

http://maya.tase.co.il/bursa/report.asp?report_cd=919192-00&CompCd=1267&Type=Pdf